InMed Pharmaceuticals (INM) News Today $0.26 -0.01 (-3.70%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period InMed Pharmaceuticals Files Additional Patent Application for INM-901 Targeting Neurodegenerative DiseasesVANCOUVER, BRITISH COLUMBIA–October 28, 2024 - Today, InMed Pharmaceuticals Inc. (NASDAQ: INM) disclosed in an 8-K SEC filing that theOctober 31 at 2:13 AM | americanbankingnews.comFinancial Analysis: GeoVax Labs (NASDAQ:GOVX) & InMed Pharmaceuticals (NASDAQ:INM)October 28, 2024 | americanbankingnews.comHead-To-Head Comparison: InMed Pharmaceuticals (NASDAQ:INM) and Medivir AB (publ) (OTCMKTS:MVRBF)October 26, 2024 | americanbankingnews.comInMed Pharmaceuticals sets date for annual shareholder meetingSeptember 28, 2024 | investing.comInMed Pharmaceuticals’ (NASDAQ: INM) INM-901: A Promising Candidate for Alzheimer’sAugust 31, 2024 | theglobeandmail.comInMed Pharmaceuticals (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901August 28, 2024 | theglobeandmail.comInMed Pharmaceuticals (NASDAQ: INM) Announces Three U.S. Patent IssuancesAugust 23, 2024 | theglobeandmail.comBiotech Already Up Over +300% During Premarket HoursAugust 20, 2024 | msn.comBioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s TreatmentAugust 20, 2024 | msn.comInMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On TuesdayAugust 20, 2024 | msn.comInMed Pharmaceuticals Inc. (MWG0.F)August 14, 2024 | sg.finance.yahoo.comInMed Pharmaceuticals Inc (MWG0.SG)August 14, 2024 | sg.finance.yahoo.comInMed Pharmaceuticals consultant sells company sharesAugust 4, 2024 | investing.comInMed Pharmaceuticals (NASDAQ: INM) Reports Long-Term Study Results on Treatment for ADJuly 31, 2024 | theglobeandmail.comInMed’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular DegenerationJuly 25, 2024 | theglobeandmail.comInMed (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMDApril 17, 2024 | theglobeandmail.comInMed Pharmaceuticals (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day ExtensionMarch 23, 2024 | theglobeandmail.comInMed Pharmaceuticals Welcomes New CFO Neeta JagpalFebruary 10, 2024 | markets.businessinsider.comInMed Pharmaceuticals Announces New CFO AppointmentFebruary 10, 2024 | msn.comInMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial OfficerFebruary 9, 2024 | finance.yahoo.comInMed Pharmaceuticals Has Multiple Milestones Coming Up In 2024, With A Focus On Three Conditions With An Unmet NeedJanuary 25, 2024 | benzinga.comInMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ETJanuary 18, 2024 | finance.yahoo.comInMed Pharmaceuticals: InMed Announces Results of 2023 Annual General MeetingDecember 20, 2023 | finanznachrichten.deInMed Announces Results of 2023 Annual General MeetingDecember 19, 2023 | finance.yahoo.comInMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business UpdateNovember 14, 2023 | finance.yahoo.comInMed Pharmaceuticals files to sell 12.57M shares for holdersNovember 8, 2023 | msn.comInMed Pharmaceuticals Inc INMNovember 8, 2023 | morningstar.comInMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023November 2, 2023 | finance.yahoo.comInMed Pharmaceuticals Announces the Closing of $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq RulesOctober 27, 2023 | finance.yahoo.comWhy Is InMed Pharmaceuticals (INM) Stock Down 25% Today?October 25, 2023 | investorplace.comInMed Pharmaceuticals to raise $5.2M via private placementOctober 24, 2023 | msn.comInMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq RulesOctober 24, 2023 | finance.yahoo.comDow Surges 250 Points; US Manufacturing PMI Tops ExpectationsOctober 24, 2023 | benzinga.comWhy InMed Pharmaceuticals Stock Is Soaring TuesdayOctober 24, 2023 | benzinga.comTrading was temporarily halted for "INM" at 10:10 AM with a stated reason of "LULD pause." Trading set to resume at 10:10 AM. October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comTrading was temporarily halted for "INM" at 09:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comInMed Pharmaceuticals (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate UpdateOctober 3, 2023 | theglobeandmail.comInMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business UpdateSeptember 29, 2023 | finance.yahoo.comThis Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness SectorSeptember 15, 2023 | benzinga.comInMed to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 7, 2023 | finance.yahoo.comINM - InMed Pharmaceuticals Inc.July 22, 2023 | au.finance.yahoo.comInMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ETJuly 21, 2023 | finance.yahoo.comWhy Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJune 22, 2023 | msn.comWhy Are InMed Pharmaceuticals Stock Trading Lower TodayJune 22, 2023 | finance.yahoo.comInMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis BullosaJune 22, 2023 | finance.yahoo.comStudy Unveils Rare Cannabinoid As Promising Hope For Alzheimer's, Parkinson's & Huntington's TreatmentJune 1, 2023 | msn.comInMed Pharmaceuticals: InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience MeetingJune 1, 2023 | finanznachrichten.deInMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience MeetingJune 1, 2023 | finance.yahoo.com Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, INM Media Mentions By Week INM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INM News Sentiment▼0.000.44▲Average Medical News Sentiment INM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INM Articles This Week▼20▲INM Articles Average Week Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADXN News NKGN News GLYC News RDHL News PHXM News ORGS News KPRX News CANF News KZIA News VIRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
